New Round of Late-Breaking Clinical Trials Announced at VIVA21

/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...

Related Keywords

Singapore ,Boston ,Massachusetts ,United States ,Wynn Las Vegas ,Ehrin Armstrong ,Yann Gou ,Tjun Tang ,Robert Lookstein ,Boston Scientific Corporation ,Peripheral Academic Research Consortium ,Society Consensus ,Medtronic ,Wynn Las ,Vascular Interventional Advances ,Month Outcomes ,Primary Results ,Randomized Trial ,Sirolimus Drug Eluting Balloons ,Complex Below The Knee Atherosclerotic Disease ,Patients With Chronic Limb Threatening Ischemia ,Month Results From ,Transatlantic Inter Society Consensus ,Walking Impairment Questionnaire ,Mean Rutherford ,Peripheral Artery Calcification ,Interim Analysis ,Shockwave Medical ,The Viva Foundation ,